Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Chemistry and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1074-5521(99)80019-2PMID 9889151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Situ Neutralization in Boc-chemistry Solid Phase Peptide Synthesis

  2007cited by this paper
• Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity

  1998cited by this paper
• Effect of N-terminal truncation and solution conditions on chemokine dimer stability: nuclear magnetic resonance structural analysis of macrophage inflammatory protein 1 beta mutants.

  1998cited by this paper
• Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

  1997cited by this paper
• The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions

  1997cited by this paper
• Synthesis and evaluation of fluorescent chemokines labeled at the amino terminal.

  1997cited by this paper
• SHELXL: high-resolution refinement.

  1997cited by this paper
• Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5.

  1997cited by this paper
• Identification of a Glycosaminoglycan-binding Site in Chemokine Macrophage Inflammatory Protein-1α*

  1997cited by this paper
• Glycosaminoglycans mediate cell surface oligomerization of chemokines.

  1997cited by this paper
• Modulation of Reactivity in Native Chemical Ligation through the Use of Thiol Additives

  1997influential reference
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP‐1α, MIP‐1β, and RANTES

  1996cited by this paper
• Molecular Cloning and Functional Characterization of a Novel Human CC Chemokine Receptor (CCR5) for RANTES, MIP-1β, and MIP-1α*

  1996cited by this paper
• RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors (*)

  1996cited by this paper
• Molecular cloning and functional expression of a new human CC-chemokine receptor gene.

  1996cited by this paper
• Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*)

  1996cited by this paper
• The three-dimensional solution structure of RANTES.

  1995influential reference
• Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients

  1995cited by this paper
• Structure‐activity relationships of chemokines

  1995cited by this paper
• Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

  1995cited by this paper
• Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)‐1β production by synovial T cells

  1995cited by this paper
• Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

  1995cited by this paper
• Cloning and Functional Expression of a Human Eosinophil CC Chemokine Receptor (*)

  1995cited by this paper
• Monocyte Chemotactic Protein-3 (MCP3) Interacts with Multiple Leukocyte Receptors

  1995cited by this paper
• Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type.

  1995influential reference
• Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA from a Human Basophilic Cell Line (*)

  1995cited by this paper
• Compartmentalized expression of RANTES in a murine model of endotoxemia.

  1995cited by this paper
• Synthesis of proteins by native chemical ligation.

  1994cited by this paper
• Raster3D Version 2.0. A program for photorealistic molecular graphics.

  1994cited by this paper
• Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor.

  1993cited by this paper
• Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor

  1993cited by this paper
• Computational challenges for macromolecular structure determination by X-ray crystallography and solution NMRspectroscopy

  1993cited by this paper
• Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors.

  1993cited by this paper
• X-PLOR Version 3.1: A System for X-ray Crystallography and NMR

  1992cited by this paper
• Polypeptide Synthesis Using the S-Alkyl Thioester of a Partially Protected Peptide Segment. Synthesis of the DNA-Binding Domain of c-Myb Protein (142–193)–NH2

  1991cited by this paper
• A program to produce both detailed and schematic plots of protein structures

  1991cited by this paper
• RIBBONS 2.0

  1991cited by this paper
• Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

  1990cited by this paper
• Chemical synthesis of peptides and proteins.

  1988cited by this paper
• Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features

  1983cited by this paper
• Chemical synthesis of peptides and proteins.

  1970cited by this paper

• Advances in the chemical synthesis of human proteoforms

  2025cites this paper
• Endogenous Peptide Inhibitors of HIV Entry.

  2022cites this paper
• Characterization of Protein Molecules Prepared by Total Chemical Synthesis

  2021cites this paper
• Chemical Protein Synthesis by Native Chemical Ligation and Variations Thereof

  2019cites this paper
• Novel protein science enabled by total chemical synthesis

  2019cites this paper
• Chemoenzymatic Semisynthesis of Proteins.

  2019cites this paper
• Integrative model to coordinate the oligomerization and aggregation mechanisms of CCL5

  2019cites this paper
• Amide-Forming Ligation Reactions

  2019cites this paper
• The solution structure of monomeric CCL5 in complex with a doubly sulfated N‐terminal segment of CCR5

  2018cites this paper
• Synthesis of Chemokines by Chemical Ligation

  2017cites this paper
• A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris

  2016cites this paper
• Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3

  2016influential citation
• Spurlose Aufreinigung und Desulfurierung von Ligationsprodukten des Tau‐Proteins

  2015cites this paper
• CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells

  2015cites this paper
• Acceleration of thiol additive-free native chemical ligation by intramolecular S → S acyl transfer.

  2015cites this paper
• Mécanismes de résistance aux inhibiteurs de CCR5

  2015cites this paper
• Traceless purification and desulfurization of tau protein ligation products.

  2015cites this paper
• RP105 involved in activation of mouse macrophages via TLR2 and TLR4 signaling

  2013cites this paper
• Peptide and protein-based inhibitors of HIV-1 co-receptors

  2013cites this paper
• α-Oxo aldehyde or glyoxylyl group chemistry in peptide bioconjugation.

  2013cites this paper
• Protein structural investigation using hydroxyl radical protein footprinting

  2012cites this paper
• Engineering and screening the N-terminus of chemokines for drug discovery.

  2011cites this paper
• Molecular Dynamics Simulations of CXCL-8 and Its Interactions with a Receptor Peptide, Heparin Fragments, and Sulfated Linked Cyclitols

  2011cites this paper
• Héparanes sulfate : Structure, fonctions, régulation

  2011cites this paper
• Molecular engineering of RANTES peptide mimetics with potent anti‐HIV‐1 activity

  2011cites this paper
• Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data.

  2011cites this paper
• Nepsilon-(thiaprolyl)-lysine as a handle for site-specific protein conjugation.

  2010cites this paper
• Chemical Synthesis and Engineering ofCytokines of Potential Therapeutic Interest

  2008cites this paper
• Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein.

  2008cites this paper
• Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccination.

  2008cites this paper
• Structural and functional studies of the potent anti‐HIV chemokine variant P2‐RANTES

  2008cites this paper
• Aminoacyl-tRNA synthetase-interacting multi-functional protein 1/p43: an emerging therapeutic protein working at systems level

  2008cites this paper
• Rational design of novel HIV-1 entry inhibitors by RANTES engineering.

  2008cites this paper
• A Novel Route for Construction of Multipurpose Receptors through Chemical Modification of Glutathione Transferases

  2008cites this paper
• Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4.

  2008cites this paper
• A chemical approach to the pharmaceutical optimization of an anti-HIV protein.

  2007cites this paper
• Structural and functional characterization of CC chemokine CCL14.

  2007cites this paper
• Recognition of RANTES by extracellular parts of the CCR5 receptor.

  2007cites this paper
• Evaluation of -2 RANTES Vaginal Microbicide Formulations in a Nonhuman Primate Simian/Human Immunodeficiency Virus (SHIV) Challenge Model

  2007cites this paper
• Analysis of HIV-1-X4 fusion with immature dendritic cells identifies a specific restriction that is independent of CXCR4 levels.

  2007cites this paper
• N‐terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4‐68 variant

  2006cites this paper
• Preclinical Evaluation of Synthetic −2 RANTES as a Candidate Vaginal Microbicide To Target CCR5

  2006cites this paper
• The synergy of ChemMatrix resin and pseudoproline building blocks renders RANTES, a complex aggregated chemokine.

  2006cites this paper
• His6 tag-assisted chemical protein synthesis.

  2005cites this paper
• Site-specific polymer modification of therapeutic proteins.

  2005cites this paper
• Crystal structure of viral macrophage inflammatory protein I encoded by Kaposi's sarcoma-associated herpesvirus at 1.7A.

  2005cites this paper
• PSC-RANTES Blocks R5 Human Immunodeficiency Virus Infection of Langerhans Cells Isolated from Individuals with a Variety of CCR5 Diplotypes

  2004cites this paper
• Total chemical synthesis and electrophysiological characterization of mechanosensitive channels from Escherichia coli and Mycobacterium tuberculosis.

  2004cites this paper
• The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors.

  2004cites this paper
• Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.

  2004cites this paper
• Human Immunodeficiency Virus Type 1 Entry Inhibitors Selected on Living Cells from a Library of Phage Chemokines

  2003cites this paper
• , by N-Terminal Modifications of RANTES Immunodeficiency Virus Type 1 Inhibition Two Mechanisms for Human

  2003cites this paper
• Structures of thymus and activation-regulated chemokine (TARC).

  2003cites this paper
• Crystallization and preliminary X-ray studies of thymus and activation-regulated chemokine (TARC).

  2003cites this paper
• Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES

  2003cites this paper
• Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity.

  2003cites this paper
• A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization.

  2002cites this paper
• Designing decoys for chemokine-chemokine receptor interaction.

  2002cites this paper
• Rational development of an anti-HIV protein active at low picomolar concentrations

  2002cites this paper
• Recognition of RNA and DNA targets by peptide nucleic acids

  2002cites this paper
• Heparin-aggregated RANTES can be crystallised.

  2002cites this paper
• Considerations and development of topical microbicides to inhibit the sexual transmission of HIV

  2002cites this paper
• Chemical synthesis of lymphotactin: a glycosylated chemokine with a C-terminal mucin-like domain.

  2001cites this paper
• Fmoc-based synthesis of the human CC chemokine CCL14/HCC-1 by SPPS and native chemical ligation

  2001cites this paper
• Structural and functional analysis of the RANTES-glycosaminoglycans interactions.

  2001cites this paper
• Donor- and Ligand-Dependent Differences in C-C Chemokine Receptor 5 Reexpression

  2001cites this paper
• Chemokine receptors as anti-retroviral targets.

  2001cites this paper
• Homology modeling and molecular dynamics simulations of lymphotactin

  2000cites this paper
• Challenges for protein chemical synthesis in the 21st century: bridging genomics and proteomics.

  2000cites this paper
• Synthesis of native proteins by chemical ligation.

  2000cites this paper
• A novel anti-tumor cytokine contains an RNA binding motif present in aminoacyl-tRNA synthetases.

  2000cites this paper
• Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors.

  2000cites this paper
• Peptide ligation and its application to protein engineering.

  1999cites this paper
• Design, total chemical synthesis, and binding properties of a [Leu-91-N1-methyl-7-azaTrp]Ras-binding domain of c-Raf-1.

  1999cites this paper
• Chemical protein synthesis.

  1999cites this paper
• Introduction of unnatural amino acids into proteins using expressed protein ligation.

  1999cites this paper